HK1083769A1 - Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same - Google Patents

Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same

Info

Publication number
HK1083769A1
HK1083769A1 HK06106212.3A HK06106212A HK1083769A1 HK 1083769 A1 HK1083769 A1 HK 1083769A1 HK 06106212 A HK06106212 A HK 06106212A HK 1083769 A1 HK1083769 A1 HK 1083769A1
Authority
HK
Hong Kong
Prior art keywords
producing
same
digestive tract
agent improving
mediated absorption
Prior art date
Application number
HK06106212.3A
Other languages
English (en)
Inventor
Akira Tsuji
Ikumi Tamai
Yoshimichi Sai
Masaaki Odomi
Hidekazu Toyobuku
Original Assignee
Akira Tsuji
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Tsuji, Otsuka Pharma Co Ltd filed Critical Akira Tsuji
Publication of HK1083769A1 publication Critical patent/HK1083769A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06106212.3A 2003-01-14 2006-05-29 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same HK1083769A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003006005 2003-01-14
PCT/JP2004/000070 WO2004062691A1 (ja) 2003-01-14 2004-01-08 プロトン駆動型トランスポーター介在型消化管吸収改善剤及びその製法

Publications (1)

Publication Number Publication Date
HK1083769A1 true HK1083769A1 (en) 2006-07-14

Family

ID=32709038

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106212.3A HK1083769A1 (en) 2003-01-14 2006-05-29 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same

Country Status (11)

Country Link
US (3) US20060121107A1 (xx)
EP (1) EP1588715A4 (xx)
JP (2) JP5175032B2 (xx)
KR (1) KR100691568B1 (xx)
CN (1) CN1735435B (xx)
AR (1) AR042846A1 (xx)
AU (1) AU2004204541B2 (xx)
CA (1) CA2508932C (xx)
HK (1) HK1083769A1 (xx)
TW (1) TWI355276B (xx)
WO (1) WO2004062691A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102908332B (zh) * 2011-08-04 2014-04-16 纳米及先进材料研发院有限公司 用于口服胰岛素递送的包含阳离子纳米粒子的肠溶包衣胶囊

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US4224929A (en) * 1977-11-08 1980-09-30 Olympus Optical Co., Ltd. Endoscope with expansible cuff member and operation section
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
KR0157280B1 (ko) * 1992-11-06 1998-11-16 나까토미 히로타카 하부소화관 방출성의 경구의약제제
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
US5728402A (en) * 1994-11-16 1998-03-17 Andrx Pharmaceuticals Inc. Controlled release formulation of captopril or a prodrug of captopril
WO1996020001A1 (fr) * 1994-12-28 1996-07-04 Teikoku Hormone Mfg. Co., Ltd. Preparation traversant la muqueuse
JPH09188617A (ja) * 1996-01-08 1997-07-22 Pola Chem Ind Inc 徐放性医薬組成物
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US5851985A (en) * 1996-08-16 1998-12-22 Tepic; Slobodan Treatment of tumors by arginine deprivation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EA003101B1 (ru) * 1998-03-19 2002-12-26 Бристол-Майерз Сквибб Компани Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы
JP2000086535A (ja) * 1998-09-14 2000-03-28 Eisai Co Ltd 遅延型速放固形製剤及びその製法
KR100762475B1 (ko) * 1998-11-27 2007-10-04 칸지 타카다 위장내 약물 전달을 위한 경구용 제제
PT1194124E (pt) 1999-06-11 2004-02-27 Ranbaxy Lab Ltd Composicoes de sabor mascarado
KR100572506B1 (ko) * 1999-06-14 2006-04-24 데이진 가부시키가이샤 2축 배향 폴리에스테르 필름 및 자기 기록 매체
KR100863146B1 (ko) * 2000-07-17 2008-10-14 아스텔라스세이야쿠 가부시키가이샤 경구 흡수 개선 의약 조성물
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
DE60206889T2 (de) * 2001-02-27 2006-07-27 Astrazeneca Ab Pharmazeutische formulierung enthaltend bicalutamid
JP3942846B2 (ja) * 2001-06-21 2007-07-11 独立行政法人科学技術振興機構 組織特異的トランスポーター阻害剤
CN1211422C (zh) * 2001-08-01 2005-07-20 华中科技大学 用于口服结肠定位释药的聚合物凝胶及其制备方法

Also Published As

Publication number Publication date
JPWO2004062691A1 (ja) 2006-05-18
KR100691568B1 (ko) 2007-03-09
TWI355276B (en) 2012-01-01
US20090048350A1 (en) 2009-02-19
JP5175032B2 (ja) 2013-04-03
US20080119568A1 (en) 2008-05-22
CA2508932A1 (en) 2004-07-29
US20060121107A1 (en) 2006-06-08
CA2508932C (en) 2012-01-03
TW200413007A (en) 2004-08-01
US8871818B2 (en) 2014-10-28
JP2010280705A (ja) 2010-12-16
EP1588715A4 (en) 2011-05-25
AU2004204541B2 (en) 2008-10-16
WO2004062691A1 (ja) 2004-07-29
KR20050100369A (ko) 2005-10-18
AR042846A1 (es) 2005-07-06
CN1735435B (zh) 2012-08-29
EP1588715A1 (en) 2005-10-26
AU2004204541A1 (en) 2004-07-29
CN1735435A (zh) 2006-02-15

Similar Documents

Publication Publication Date Title
GB0519316D0 (en) "Method and apparatus"
EG24489A (en) Reducing agent for the soluble chromate content ofcement and methods for the production thereof
IL175892A0 (en) Quinolines useful in treating cardiovascular disease
EP1785410A4 (en) MONOETHERS OF POLYGLYCEROL AND PROCESS FOR THEIR PREPARATION
EP1729881A4 (en) AQUEOUS LIQUID ABSORBENT MEDIUM AND METHOD OF MANUFACTURING THEREOF
IL172316A0 (en) Novel compounds and their use in therapy
AU2003248074A8 (en) Composite nanoparticle and process for producing the same
EP1550688A4 (en) ORGANOPOLYSILOXANE-MODIFIED POLYSACCHARIDE AND PROCESS FOR PRODUCING THE SAME
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
AU2003268003A8 (en) Diamondoid-based components in nanoscale construction
GB2418856B (en) Breath freshener and process for producing the same
HK1087893A1 (en) Masticatable capsule and process for producing the same
EP1586445A4 (en) MULTILAYER BODY AND METHOD FOR PRODUCING THE SAME
EP1698647A4 (en) POLYMER AND PROCESS FOR PRODUCING THE SAME
EP1840948A4 (en) FINE TREATMENT AGENT AND FINE TREATMENT METHOD USING THE SAME
EP1640153A4 (en) MULTILAYER BODY AND METHOD FOR PRODUCING THE SAME
EP1604710A4 (en) SURFACE MATERIAL FOR BALLOON AND BALLOON
EP1669408A4 (en) BALL-MOLDED COMPOSITION COMPOSITION AND METHOD OF MANUFACTURING THEREOF
HK1083769A1 (en) Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
EP1667174A4 (en) SUPERCONDUCTOR AND METHOD FOR PRODUCING THE SAME
EP1627645A4 (en) ANTITUMMER AGENT AND METHOD FOR PRODUCING THE SAME
SI1639013T1 (sl) Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji
GB0625794D0 (en) Condom and process for producing the same
PT1763515E (pt) Ácidos 4-trifluorometoxifenoxibenzeno-4¿-sulfónicos, processo para a sua preparação e utilização em medicamentos
EP1685822A4 (en) GLUCOSE ABSORPTION INHIBITOR AND METHOD FOR PRODUCING THE SAME

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180108